Literature DB >> 19870044

VACCINATION AGAINST YELLOW FEVER WITH IMMUNE SERUM AND VIRUS FIXED FOR MICE.

W A Sawyer1, S F Kitchen, W Lloyd.   

Abstract

1. After preliminary experiments in monkeys, 15 persons were actively immunized by a single injection of a dried mixture of living yellow fever virus, fixed for mice, and human immune serum, with separate injections of enough additional serum to make up the amount required for protection. 2. One person was similarly immunized by injecting immune serum and dried virus separately. 3. By titration of the sera of vaccinated persons in mice, it was shown that the immunity rose in a few weeks to a height comparable to that reached after an attack of yellow fever, and remained there throughout an observation period of 6 months. 4. Yellow fever virus could not be recovered from the blood of vaccinated persons or monkeys, except when the latter had received less than the minimal effective amount of immune serum. 5. Neutralization of yellow fever virus by immune serum took place very slowly in vitro at room temperature in our experiments, and could not have been an appreciable factor in vaccination with the serum virus mixtures. 6. A mixture of fixed virus and immune serum retained its immunizing power for 8 months when dried in the frozen state and sealed in glass. 7. It appears that the immunizing reaction after yellow fever vaccination was a part of a true infectious process, as was also the observed leucopenia.

Entities:  

Year:  1932        PMID: 19870044      PMCID: PMC2132143          DOI: 10.1084/jem.55.6.945

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  COMBINED USE OF LIVING VIRUS AND IMMUNE SERUM FOR IMMUNIZATION AGAINST VIRUS INFECTIONS.

Authors:  G M Findlay; E Hindle
Journal:  Br Med J       Date:  1931-05-02

2.  The Behavior of the Virus of Yellow Fever in Monkeys and Mice.

Authors:  A W Sellards
Journal:  Proc Natl Acad Sci U S A       Date:  1931-06       Impact factor: 11.205

3.  THE USE OF MICE IN TESTS OF IMMUNITY AGAINST YELLOW FEVER.

Authors:  W A Sawyer; W Lloyd
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

4.  THE PRESERVATION OF YELLOW FEVER VIRUS.

Authors:  W A Sawyer; W D Lloyd; S F Kitchen
Journal:  J Exp Med       Date:  1929-06-30       Impact factor: 14.307

  4 in total
  7 in total

1.  A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity.

Authors:  Srilatha Edupuganti; Rachel B Eidex; Harry Keyserling; Rama S Akondy; Robert Lanciotti; Walter Orenstein; Carlos del Rio; Yi Pan; Troy Querec; Harvey Lipman; Alan Barrett; Rafi Ahmed; Dirk Teuwen; Martin Cetron; Mark J Mulligan
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

Review 2.  Current status and future prospects of yellow fever vaccines.

Authors:  Andrew S Beck; Alan D T Barrett
Journal:  Expert Rev Vaccines       Date:  2015-09-14       Impact factor: 5.217

Review 3.  TICK-BORNE VIRUSES. A REVIEW OF AN ARTHROPOD-BORNE VIRUS PROBLEM OF GROWING IMPORTANCE IN THE TROPICS.

Authors:  T H WORK
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

4.  THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS.

Authors:  M Theiler; H H Smith
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

5.  THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION.

Authors:  M Theiler; H H Smith
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

6.  FURTHER STUDIES ON TYPHUS FEVER : ON HOMOLOGOUS ACTIVE IMMUNIZATION AGAINST THE EUROPEAN STRAIN OF TYPHUS FEVER.

Authors:  H Zinsser; A Macchiavello
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

7.  THE TRANSMISSION OF NEUROTROPIC YELLOW FEVER VIRUS BY STEGOMYIA MOSQUITOES.

Authors:  N C Davis; W Lloyd; M Frobisher
Journal:  J Exp Med       Date:  1932-11-30       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.